India’s AMR Response: High-level leadership and Implementation challenges

2026-01-28

On 28 December 2025, India's Prime Minister Narendra Modi used his ‘Mann Ki Baat’ (Speaking my Mind) broadcast to reach millions of Indian households to deliver a direct public message on antimicrobial resistance. Drawing on evidence from the Indian Council of Medical Research (ICMR), he cautioned citizens against "mindless" self-medication with antibiotics and emphasized that these medicines should only be taken on a doctor's advice. By citing specific ICMR data through a platform known for its personal, conversational tone, Prime Minister Modi shifted antimicrobial resistance from the confines of microbiology laboratories and policy documents into public consciousness - a turning point that has positioned antibiotic stewardship as both a personal and collective responsibility.

Policy framework and high-level commitment

Modi’s intervention lends considerable political weight to India’s second National Action Plan on Antimicrobial Resistance (NAP-AMR 2.0, 2025–2029). The plan coordinates over 20 ministries and departments, each with defined budgets and timelines, embedding One Health principles across human, animal and environmental sectors. When leadership at the highest level cites ICMR surveillance data, it reinforces institutional accountability and signals that AMR control is a cabinet-level priority rather than a technical matter delegated solely to health specialists.

Regulatory measures have been simultaneously strengthened in the country. Schedule H1 (Drugs and Cosmetics Act, 1940) provisions restrict antibiotics to prescription-only sales, requiring mandatory pharmacy registers; the Red Line Campaign visually marks antibiotic packs to signal this status.

A draft notification issued in January 2026 proposes that all antimicrobial drugs bear a conspicuous blue vertical strip on the left side of labels, running throughout without disturbing other printed information. This marking system aims to create unmistakable visual recognition at pharmacy counters, thereby supporting enforcement and appropriate dispensing practices.

From political commitment to implementation impact

India currently demonstrates a rare convergence of:

• robust evidence
• strong policy architecture and
• high-level political leadership

– an alignment that is uncommon in resource-constrained health systems and that creates a critical window of opportunity to accelerate the implementation of antimicrobial stewardship.

However, the translation of policy into measurable clinical and epidemiological change will ultimately be determined by implementation at ground level:

• in primary health centers where diagnostic capacity is limited
• in pharmacy settings where commercial and prescriber incentives shape behavior and
• in communities where expectations and practices around antibiotic use remain deeply entrenched.

Bridging this policy-practice gap is the defining challenge of the next phase.

Systematic collection and analysis of ground-level evidence is therefore critical. This requires documenting which stewardship approaches demonstrate efficacy in resource-limited primary care settings, how community-based messaging influences antibiotic-seeking behavior, and where specific policy-practice gaps create barriers to implementation. Only through such evidence can political momentum be converted into sustained, measurable practice change.